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Abstract
Cationic lipid-mediated gene transfer has been shown to be a competent albeit inefficient mechanism of promoting
cellular gene transfer. One way to improve the efficacy of cationic lipid-mediated transgene expression is to optimize
conditions for complex formation between the lipids and nucleic acids. In this report we describe the beneficial effects of
  . w  . xusing phosphate buffer to precondition lipofectin a 1:1 wrw mixture of N- 1- 2,3-dioleyloxy propyl -n,n,n-trimethyl-
 .  ..ammonium chloride DOTMA , and dioleoyl phosphatidylethanolamine DOPE prior to complexing with plasmid DNA or
mRNA. Under such optimized conditions we studied the kinetics of DNA- and RNA-mediated transgene expression in a
 .human osteosarcoma cell line HOS . Preincubation of lipofectin in phosphate buffer resulted in up to 26- and 56-fold
 .increases in luciferase expression from plasmid DNA and mRNA, respectively. Addition of chloroquine 50 mM , which
enhanced plasmid-mediated gene delivery 3-fold, was synergistic with phosphate resulting in an additional 46-fold increase
in luciferase expression. The preincubation with phosphate shortened both the time required for cellular uptake and the time
to achieve maximal transgene expression. Optimal transfection was achieved in the presence of 30–80 mM phosphate, at pH
5.6–6.8 under which the phosphate anion is divalent. The effect of phosphate anion was specific in that monovalent Cl- and
acetate anions were not stimulatory. These results demonstrate that divalent phosphate anion plays a stimulatory role during
complex formation and transfection when cationic lipids come in contact with negatively charged nucleic acids and cell
membranes. These findings delineate specific conditions which dramatically enhance transfection efficiency for both DNA
and mRNA, and provide an effective procedure for gene transfection studies. q 1998 Elsevier Science B.V.
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1. Introduction
The use of gene therapeutic approaches in the
treatment of disease has received increasing interest.
Viral based delivery has proved thus far to be the
most efficacious form of gene delivery. Viral thera-
pies however have a number of limitations including
variable transfection efficiencies, activation of host
immune response, concern over possible viral recom-
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w xbination and cellular toxicity 1,2 . Non-viral delivery
systems have been developed with the hope of over-
coming some of the problems associated with viral
 w x.gene delivery for review see 3 . In non-viral meth-
ods some type of lipid vehicle, usually cationic lipo-
some, is employed to deliver plasmid DNA or in
w xvitro transcribed mRNA to the target cells 4,5 .
Evaluation of transfection efficiency usually involves
comparison of different formulations using transgene
expression as the endpoint. Cationic lipid transfer,
however, results in relatively low transfection effi-
ciency when compared to the viral systems, although
w xprogress in this process of so called ‘‘lipofection’’ 6
has been made throughout the years, which has re-
w xsulted in improvements in gene transfer 7 . Potent
w xvectors have been developed 8,9 , novel lipids have
w xbeen introduced 8,10,11 and complex formulations
w xhave been optimized 10,12–14 . Advancements have
also been made in the physico-chemical characteriza-
tion of the DNArcationic lipid interaction during
w x w xcomplex formation 15,16 and cell transfection 17 .
The physical structure of the complex has been inves-
tigated by metal-shadowing, freeze-fracture and
w xtransmission electron microscopies 18–22 , and more
recently by combined in situ optical microscopy and
w xx-ray diffraction 23 .
Despite all of this progress and utilization of so-
phisticated tools, the new lipofection protocols are
developed empirically by trial-and-error methods.
This is largely due to the fact that the kinetics of
complex formation between nucleic acid and lipid
carrier, and the mechanisms of cellular uptake and
intracellular trafficking of the complex remains poorly
w xunderstood 22,24 . Little is known concerning the
individual parameters that influence complex forma-
tion and the characteristics of the complex that are
relevant to transfection efficiencies in gene therapy
w x10,13,22,25 . A better understanding of these molec-
ular and cellular mechanisms would lead to a rational
approach in the design of cationic lipid–nucleic acid
complex, and subsequently to an improvement of
gene transfer methods.
The aim of the present study was to evaluate the
ability of phosphate anions to improve cationic lipid-
mediated gene transfer. An established cell line was
used to test the expression of luciferase reporter
protein from template plasmid DNA or from in vitro
mRNA transcripts. We demonstrate that when lipo-
fectin is preincubated with sodium or potassium
phosphate buffer the transfection efficiency of both
RNA and DNA is dramatically improved. This bene-
ficial effect of phosphate buffer was concentration
and pH-dependent, specific, and resulted in acceler-
ated protein expression. The relatively simple modifi-
cations described here have profound effects on the
ability to efficiently transfect a wide variety of cell
types with both mRNA as well as DNA. Finally, on
the basis of these findings, we propose a mechanism
to explain the effects of divalent phosphate anions
upon the process of gene transfer.
2. Materials and methods
2.1. Cells, plasmid DNA and mRNA
 .A human osteosarcoma cell line HOS was ob-
tained from American Type Culture Collection
 .ATCC, Rockville, MD and cultured in Dulbecco’s
 .modified Eagle’s medium DMEM supplemented
 .with 10% fetal calf serum FCS . Cell viability was
assayed using Trypan blue exclusion test. For DNA
transfection studies we utilized pCMVintLucD5X gene
expression plasmid vector which was a gift from Dr.
Kris Fisher. This vector consisted of the full coding
region of firefly P. pyralis luciferase cDNA driven
by the human cytomegalovirus promoter. The 5530 bp
plasmid also contained a polyadenylation signal and
5X upstream intron sequences that were both SV40-re-
lated. For mRNA transfection we employed synthetic
mRNA transcripts obtained by in vitro synthesis. The
DNA template plasmid pT7-TEV-LUC-A50 was a
gift from Dr. Daniel Gallie. Transcript derived from
this plasmid contained the luciferase coding region,
leader of the tobacco etch viral RNA, and polyA tail.
The pT7-TEV-LUC-A50 plasmid was first linearized
at a NdeI site 3X to the incorporated stretch of 50 bp
dA:dT. The linearized and purified DNA template
was then used to synthesize the luciferase encoding
X 5 -capped transcript using MessageMachine kit Am-
.bion, Austin, TX according to the manufacturer.
Purification of the 1.8 kb transcript was performed by
DNase I digestion followed by LiCl precipitation and
washing with 75% ethanol. The quality of each batch
of purified mRNA was tested by agarose gelelec-
trophoresis for degradation and for presence of con-
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taminating DNA template. Plasmids were purified
 .using the Qiagen kit Qiagen, Santa Clarita, CA . The
plasmid DNA and mRNA samples were quantitated
by measuring O.D. at 260 nm. Samples were stored
frozen at y208C in 0.5–1.0 mgrml final concentra-
tions.
2.2. Preparation of the complex
Sodium and potassium phosphate buffers with dif-
ferent pH were prepared by combining different vol-
w xumes of the appropriate 1 M solutions 26 . The stock
solutions were prepared by making 0.1–1.0 M dilu-
 .tions of the 1 M buffers pH 4.0–9.2 and supple-
menting them with 1 mgrml bovine serum albumin
 .  .BSA Sigma, St. Louis, MO . All stock solutions
were kept in polypropylene Eppendorf tubes at
y208C. Lipofectin was obtained from Gibco BRL
 .Gaithesburg, MD .
First, dilutions were prepared using serum-free
cold DMEM with high glucose content. The stock
phosphate buffer was diluted 10-fold to 10–100 mM,
and nucleic acids were diluted to 0.07 mgrml concen-
tration. Usually 0.23 mg nucleic acid was complexed
with 0.8 mg lipofectin for transfecting cells in 1 well
of a 96-well plate. Since experiments were performed
 .in triplicate, 2.4 ml lipofectin 2.4 mg was added to
21.3 m l phosphate buffer diluent containing
0.1 mgrml BSA, and incubated for 10 min at room
temperature in a 0.5 ml polypropylene tube. Then
 .9.9 ml nucleic acid 0.69 mg was added and the
mixture was further incubated for 10 min at room
 .temperature. Finally 116.4 ml prewarmed 378C
DMEM was added to bring up the final volume to
150 ml. The mixture was vortexed and 45ml of it was
added directly to 3 wells of a 96-well plate contain-
ing confluent culture of 2=104 cells per well each.
Transfected cells were incubated for 1 h at 378C in a
5% CO incubator. The mixture was then replaced2
with fresh prewarmed culture medium containing
10% FCS, and further incubated. The incubations
were terminated 5 h or 24 h after the initiation of
transfection when mRNA or plasmid DNA was used,
respectively. In some experiments freshly made
 .50 mM chloroquine Sigma was also present in the
transfection mixture. In control experiments for com-
plexing we followed the lipofectin manufacturer rec-
ommendations. Diluted lipofectin and diluted nucleic
acid solutions were preincubated in separate tubes at
room temperature for 30 min, then combined by
adding the lipofectin solution to the nucleic acid, and
incubated for an additional 15 min before placing on
the cells. The calculated charge ratio of lipoplex
prepared as described above is 1. In the time course
experiments when cells were treated with lipoplex
longer than 1 h, we added 45ml DMEM supple-
mented with 20% FCS to the cells after the first hour
of incubation.
2.3. Analysis of luciferase expression
Following incubation, the medium was removed
from the cells and 50 ml luciferase cell culture lysis
 .reagent Promega, Madison, WI was added to each
well of the 96-well plate. The detection of luciferase
activity was performed using Promega luciferase as-
say kit. 10 ml aliquots of the 50 ml cell lysates were
analyzed for activity using LUMAT LB 950
 .BertholdrEG&G Wallac, Gaithesburg, MD lumi-
nometer with a 10 s measuring time. The background
activity obtained with non-transfected cells was ;
 .100 relative light units RLU . Using recombinant
 .luciferase Promega , it was determined that the stan-
dard curve was linear, with 1.7=107 RLU activity
corresponding to 1.4 ng luciferase. Given that the
molecular weight of luciferase is 60 kDa, 1.4 ng lu-
ciferase contains ;1.4=1010 molecules. All mea-
surements were performed in the linear range of the
standard curve. The measured activity values were
normalized for 10 mg cellular protein determined by
 .the Bradford method Bio-Rad, Hercules, CA . The
protein content of ;2=104 HOS cells that were
present in a well of a 96-well plate during transfec-
tion was ;10 mg. Data represent RLU values ob-
tained from cells present in 1 well.
2.4. Data analysis
Experiments were performed in triplicate, and each
experiment was repeated independently several times.
Data are shown as means of individual experiments.
We detected some level of variation with different
batches of lipofectin. Statistical analyses of the mea-
sured activities were performed using 2-tailed Stu-
dent’s t-test. A probability of less than 0.05 was
considered to be statistically significant.
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3. Results
3.1. The effect of potassium phosphate supplementa-
tion on the efficiency of lipofection
In an attempt to improve gene delivery we tested
the stimulatory effect of chloroquine and viral protein
isolates on the efficiency of lipofection of plasmid
DNA and mRNA. After performing the appropriate
control experiments, the stimulatory effect first at-
tributed to the proteins was indeed elicited by the
small amount of potassium phosphate buffer that was
present in the isolates. To demonstrate the effect of
the buffer, lipofectin was preincubated in DMEM
supplemented with 20 mM potassium phosphate
 .buffer pH 6.4 and BSA 100 ngrml prior to com-
plexing with plasmid DNA. The complex was then
further diluted with DMEM, delivered to human os-
 .teosarcoma cell line HOS and luciferase gene ex-
 .pression was evaluated. As shown in Fig. 1 A , sup-
plementation with potassium phosphate buffer had a
significant, 26-fold stimulatory effect on transfection
efficiency. Under the same experimental conditions
we also tested the effect of chloroquine. Chloroquine
has been shown to enhance gene transfection, includ-
ing cationic lipid-mediated gene transfer by its lyso-
somotropic activity which can enable escape of endo-
w xcytosed materials from the endosome 10 . Chloro-
quine increased gene delivery to HOS by 3-fold, and
also had a synergistic effect on the phosphate buffer-
mediated enhanced plasmid transfection which re-
sulted in a 46-fold increase in luciferase production
  ..Fig. 1 A . The effect of chloroquine and phosphate
buffer was also tested on lipofectin-mediated mRNA
transfection. Using this type of formulation the mRNA
transfection was increased 56-fold. The treatment
caused no obvious cytotoxicity, although the transfec-
tion complex was kept on the cells for only 1 h.
Fig. 1. Phosphate enhances cationic lipid-mediated DNA and RNA transfection. Transfection complex was prepared by mixing 0.23 mg
luciferase-encoding plasmid DNA or mRNA with 0.8 mg lipofectin as described in Section 2. Complexes were added to a confluent
 .monolayer of human osteosarcoma cell line HOS seeded in a 96-well microtiter plate. After a 1 h treatment, the transfection mix was
 .  X.replaced with culture medium and the cells were further incubated. A Expression of luciferase from a DNA template pCMVintLucD5
 .  .was assayed at 24 h post-transfection and from B an RNA template mTEV-LUC-A50 5 h after initiation of transfection. Lysates were
normalized for protein content. The approximately 2=104 cells present in each well contained ;10 mg protein. Prior to complexing, the
 q .lipofectin was preincubated in DMEM containing 20 mM potassium phosphate buffer pH 6.4 and 100 ngrml BSA K phosphate .
 .Where it is labeled chloroquine , 50 mM chloroquine was present during the 1 h transfection. Control cells were transfected with
 .non-pretreated lipofectin and without chloroquine addition control . Data represent the mean "SD for triplicates after correction for
background. Statistical differences from the controls are labeled ) P-0.05.
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3.2. The effect of different counterion supplementa-
tion on cationic lipid-mediated transfection efficiency
To test if the increased gene transfection efficiency
elicited by potassium phosphate was mediated by
potassium, we compared the effect of KCl and NaCl
to that of potassium phosphate. We found that KCl
and NaCl were ineffective in enhancing lipofectin-
mediated plasmid DNA delivery under the same ex-
perimental conditions where potassium phosphate had
  ..significant effect Fig. 2 A . We also tested whether
the effect of potassium phosphate on gene transfec-
tion was phosphate specific. We subjected the lipo-
fectin to 20 mM sodium phosphate, potassium phos-
phate and sodium acetate buffers with pH 5.8 treat-
 .ments during the complexing process. As Fig. 2 B
demonstrates, the phosphate buffers were equally ef-
fective and increased the efficiency of lipofectin-
mediated transfection about 10-fold. However sodium
acetate supplementation during complexing inhibited
the transfection efficiency. When sodium citrate
buffer was tested we could detect modest level of
stimulation, however it was not statistically signifi-
cant and somewhat varied in different experiments
 .not shown . There was no obvious cytotoxicity re-
lated to any of the buffer treatments. These results
suggest that the enhancement of transfection effi-
ciency is phosphate specific.
3.3. Concentration-dependent effect of potassium
phosphate
We tested whether stimulation of gene transfection
by phosphate buffer supplementation was dependent
on the concentration of the buffer. We used 0.01–
0.10 M potassium phosphate buffer, pH 5.8 to pre-
treat the lipofectin prior to complexing with plasmid
DNA. In this particular experiment the cells were
exposed only for 30 min to the transfection mixture,
and 50 mM chloroquine was also present for this time
period. The results shown in Fig. 3 demonstrate that
the maximum transfection efficiency can be achieved
when the phosphate buffer concentration is between
Fig. 2. The effect of different counterions on cationic lipid-mediated DNA transfection. Transfection and luciferase assaying were
performed as described in Fig. 1 and in Section 2. Complex was prepared by mixing 0.23 mg luciferase-encoding plasmid DNA with
 .0.8 mg lipofectin that was preincubated with DMEM containing 100 ngrml BSA and one of the following solutions: 20 mM KCl KCl ,
 .  q .  q .20 mM NaCl NaCl , 20 mM potassium phosphate pH 5.8 K phosphate , 20 mM sodium phosphate pH 5.8 Na phosphate , 20 mM
 q .  .sodium acetate pH 5.8 Na acetate or none control prior to complexing. After 1 h treatment the transfection mix was replaced with
culture medium and the cells were further incubated for 23 h, when they were lysed and assayed. Lysates were normalized for protein
content. Data represent the mean "SD for triplicates after correction for background. Statistical differences from the controls are labeled
) P -0.05, )) P-0.001.
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Fig. 3. Concentration-dependent effect of potassium phosphate on
cationic lipid-mediated DNA transfection. Transfection and lu-
ciferase assaying were performed as described in Fig. 1 and in
Section 2. The complexes were prepared by mixing 0.23mg
pCMVintLucD5X with 0.8 mg lipofectin that was preincubated
with DMEM containing 100ngrml BSA and different concentra-
 .tions 10–100mM of potassium phosphate buffer pH 5.8. After
30 min treatment the transfection mix was replaced with culture
medium and the cells were further incubated for 24 h. Cells were
lysed and assayed for luciferase activity. Values are normalized
for protein contents of the lysates. Data represent the mean "SD
for triplicates after correction for background. Determinations
were made in 3 independent experiments.
0.03 and 0.08 M. Cells transfected with mixtures
prepared with 0.09 and 0.1 M phosphate buffer sup-
plementation appeared normal, so the decrease in
transfection efficiency was unlikely due to cytotoxic-
ity.
3.4. pH-dependent effect of potassium phosphate on
transfection efficiency
During pilot studies we noticed that when pH 8.0
phosphate buffer was tested for lipofectin pretreat-
ment, microscopically detectable tangled aggregates
were formed instantly. These aggregates adhered to
the cells and seemed to be toxic. To test if the pH of
the phosphate buffer was a critical parameter in
complex formation and in subsequent transfection,
we screened the effect of potassium phosphate buffer
between pH 4.0 and 9.2. The result of one of the
representative experiments in which 0.05 M potas-
sium phosphate buffer was used is shown in Fig. 4.
Data suggest that maximal enhancement of gene de-
livery can be achieved using potassium phosphate
buffer with pH 5.6–6.8. We obtained similar results
when 0.08 M phosphate buffer was tested, or when
mRNA was complexed instead of plasmid DNA. In
all cases our finding was that if the buffer pH was 7.6
or more, there was a sharp 2–4-fold drop in the
transfection efficiency. This decline is likely caused
by cytotoxicity induced by lipofectin-DNA aggre-
gates that formed during complexing. When complex
was generated with potassium phosphate buffer at pH
7.4 or 8.0, transfection resulted in partial or complete
aggregate coverage of the cells with differing degrees
of cell death evident in these wells. No cell death was
detected however in wells transfected with complexes
generated with phosphate buffer at pH 4.0–5.2. We
also tested whether the pH-dependent effect of potas-
sium phosphate is related to degradation of plasmid
Fig. 4. pH-dependent effect of potassium phosphate on cationic
lipid-mediated DNA transfection. Transfection and luciferase as-
saying were performed as described in Fig. 1 and in Section 2.
The complexes were prepared by mixing 0.23 m g
pCMVintLucD5X with 0.8 mg lipofectin that was preincubated
with DMEM containing 100ngrml BSA and 50 mM of potas-
 .sium phosphate buffer with different pH pH 4.0–9.2 . After 1 h
treatment the transfection mix was replaced with culture medium
and the cells were further incubated for 24 h. Cells were lysed
and assayed for luciferase activity. Values are normalized for
protein content of the lysates. Data represent the mean "SD for
triplicates after correction for background. Determinations were
made in 3 independent experiments. Dotted line indicates lu-
ciferase level obtained from cells transfected with complex that
was made with non-preincubated lipofectin.
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Fig. 5. Potassium phosphate inhibits cationic lipid-induced cytotoxicity. Transfection was performed as described in Section 2. The
 .  .  .complexes were prepared by mixing 0.05 mg B and C or 0.1 mg D of mRNA mTEV-LUC-A50 with 0.8 mg lipofectin that was
 .preincubated in DMEM containing 100 ngrml BSA and supplementation of 10 mM of potassium phosphate buffer pH 5.8 C , or without
 .supplementation B and D . After 1 h treatment the transfection mixes were removed and pictures were taken. Untreated cells are shown
 .in A . Similar results were obtained in 3 independent experiments.
( )K. Kariko et al.rBiochimica et Biophysica Acta 1369 1998 320–334´ 327
DNA which could occur during complexing at very
low or very high pH. In some experiments we har-
vested the medium from the cells after the 1 h incuba-
tion period and tested for the presence of intact
plasmid. All samples contained intact plasmid and no
degradative products were detectable, suggesting not
only that no pH-related degradation occurred, but
also that significant amount of plasmid is still present
in the medium at the time when the treatment with
 .the transfection mix is terminated not shown .
3.5. Phosphate diminishes cytoxicity of lipofectin
It has been long appreciated that cationic lipids can
exhibit significant cellular toxicity. It has also been
noted that cationic lipid dispersions without DNA are
w xmore toxic than those complexed with DNA 27 . We
also noticed that under our experimental conditions
non-complexed lipofectin was very toxic to HOS
 .cells not shown . Significant cell death was also
observed following treatment with lipofectin com-
  ..plexed with a low amount of RNA Fig. 5 B . The
 .charge ratio in the complex qry in that particular
 .experiment shown in Fig. 5 B was 5. When the
amount of nucleic acid was increased in the complex
and the charge ratio became 2.5 no cytotoxicity was
  ..detectable Fig. 5 D . Importantly however phos-
phate buffer could eliminate the cytotoxicity of lipo-
fectin when low concentration RNA was complexed
  ..to it Fig. 5 C . Apparently the phosphate anions act
as a charge ‘‘shield’’ by substituting for the phos-
phate of mRNA and neutralizing excess positive
charge present in the lipofectin.
3.6. Dose-response cur˝es
One of the parameters that is most frequently
tested and optimized in gene transfection protocols is
w xthe ratio of lipid and nucleic acid 10,12 . As we
described in the methods section, usually 0.23 mg
nucleic acid was complexed with 0.8 mg lipofectin
for transfecting cells in 1 well of a 96-well plate. This
ratio of nucleic acid lipofectin resulted in a qry
charge ratio of 1:1. This value seems suboptimal
when compared to those reported by others for lipo-
w xfectin 10,12 ; however, it is possible that the potas-
sium phosphate preincubation could impact upon true
charge ‘‘availability’’ through the shielding effect.
To determine the dependency of transfection effi-
ciency on nucleic acid:lipid ratio, we transfected the
cells with nucleic acid–lipofectin complex which was
prepared by complexing variable amounts of mRNA
or plasmid DNA with fixed amounts of lipofectin
which was pretreated with phosphate buffer. The
results shown in Fig. 6 suggest that ;0.1 mg mRNA
or DNA is sufficient to obtain maximal transfection
efficiency when complexed with 0.8 mg lipofectin
pretreated with 0.01 M potassium phosphate, pH 6.8.
The maximal luciferase activity elicited by the mRNA
was ;8 million RLUr10 mg protein, and by DNA
was ;32 million RLUr10 mg protein. These values
correspond to 0.65 and 2.63 ng of luciferase produc-
tion per 2=104 cells transfected with mRNA and
DNA, respectively.
We hypothesized that there could be two reasons
why the dose-curves reached saturation levels. One
reason could be that excess nucleic acid and limited
Fig. 6. Kinetics of phosphate-enhanced DNA and RNA transfec-
tion. Dose response curve. Transfection and luciferase assaying
were performed as described in Fig. 1 and in Section 2. The
complexes were prepared by mixing different amounts of plasmid
 X.  .DNA pCMVintLucD5 or mRNA mTEV-LUC-A50 with fixed
 .amounts of lipofectin 0.8 mg that was preincubated with DMEM
containing 100ngrml BSA and 10 mM potassium phosphate
buffer pH 6.8. After 1 h treatment the transfection mix was
replaced with culture medium and the cells were further incu-
bated. Cells exposed to mRNA containing complexes were lysed
5 h after initiation of the transfection. Expression of luciferase
from DNA template was assayed at 24 h post-transfection. Lysates
were normalized for protein content. Values for DNA filled
.  .triangles and mRNA filled circles are shown. Data represent
the mean "SD for triplicates after correction for background.
( )K. Kariko et al.rBiochimica et Biophysica Acta 1369 1998 320–334´328
amount of lipofectin is present during complexing, so
the nucleic acid cannot be in its effective, lipid-com-
plexed form during transfection. The other is that the
cell has limited capacity for complex uptake or ex-
pression of protein. To determine which is the limit-
ing factor, we generated two dose response curves.
One with samples prepared by complexing variable
amounts of mRNA with fixed amounts of lipofectin,
the other by using aliquots of diluted preformed
complexes. The stock complex for this latter curve
was assembled using the usual 0.23 m g
mRNAr0.8 mg pretreated lipofectin ratio. We rea-
soned that if the transfection efficiency decreased
when using diluted aliquots of the most concentrated
complex it would mean that the lipid is the limiting
Fig. 7. Kinetics of phosphate-enhanced RNA transfection. Dose
response curves. Transfection and luciferase assaying were per-
formed as described in Fig. 1 and in Section 2 here using 2
different transfection mixes. For the first transfection mix filled
.circles the complexes were prepared by mixing the indicated
 .amount of mRNA mTEV-LUC-A50 with fixed amount of
 .lipofectin 0.8 mg that was preincubated with DMEM containing
100ngrml BSA and 20 mM potassium phosphate buffer pH 6.8.
 .For the second transfection mix open squares the complex was
prepared by mixing 0.96 mg mRNA with 2.4 mg lipofectin pre-
treated as described for the first mix. The preformed complexes
were diluted in DMEM then added to the cells. After 1 h treat-
ment both transfection mixes were replaced with culture medium
and the cells were further incubated. Cells were lysed 5 h after
initiation of the transfection and assayed for expression of lu-
ciferase. Values were normalized for cytoplasmic protein content.
Data represent the mean "SD for triplicates after correction for
background. Similar results were obtained in at least 3 indepen-
dent experiments.
factor. The two dose-response curves were however
 .almost identical Fig. 7 , suggesting that at high
 .nucleic acid concentration )0.1 mgrwell excess
transfective lipid-nucleic acid complexes are present,
but cell-related parameters are limiting the transfec-
tion. This reasoning is further supported by results
from several experiments where transfection solu-
tions were reused. We could reach the same high
level of transfection efficiency by reusing a complex
solution of 0.23 mg nucleic acid and 0.8 mg lipofectin
 .exposed to cells for 1 h not shown . However the
efficiency of transfection did not increase signifi-
cantly when the incubation time was increased from
1 h. This observation not only means that there is
excess transfective complex in the solution, but also
suggests that the transfective particles are relatively
stable and the cells are imposing a limitation to
further increase the transfection efficiency.
3.7. Time course of gene expression
The time course of the transfected gene expression
depends on two time components. One is the time
required to transfer the gene to the cell, the other the
time required to transcribe and translate the gene. The
first time component is more dependent on the deliv-
ery method, while the second is dependent on the
characteristics of the cell and gene type. To learn
more about the phosphate buffer-stimulated delivery
mechanism we tried to separate the two time compo-
nents by performing different types of time course
experiments. In these studies we compared the prop-
erties of two transfection mixes. One mix was made
by complexing 0.23 mg plasmid DNA with 0.8 mg
lipofectin which was preincubated with 80 mM potas-
sium phosphate buffer, pH 6.4. The other control
transfection mix was assembled according to the
manufacturer of lipofectin using 0.23 mg DNA and
0.8 mg lipofectin. In the first time course study the
cells were treated with the transfection mix for the
 .indicated time period 20 min–5 hr , then the mix was
removed and the cells were further incubated. The
cells were lysed and assayed 24 h after initiation of
 .the transfection. Results shown in Fig. 8 A demon-
strate that gene transfer to the cell is a very rapid
process. In a short period of time, significant amounts
of DNA became associated with the cells, entered or
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Fig. 8. Kinetics of phosphate-enhanced DNA transfection. Time course experiments. Transfection and luciferase assaying were performed
as described in Fig. 1 and in Section 2. Complex was prepared by mixing 0.23 mg luciferase-encoding plasmid DNA with 0.8 mg
lipofectin that was preincubated with DMEM containing 100 ngrml BSA and supplemented with 80 mM potassium phosphate pH 6.4
 .  .  .filled circles or without supplementation open squares prior to complexing. A Cells were treated for the indicated time, then the
transfection mix was replaced with culture medium and they were further incubated. Cells were lysed 24 h after initiation of the
 .transfection and assayed for expression of luciferase. B Cells were incubated for 1 h with transfection mixes, then the transfection mix
was replaced with culture medium and they were further incubated. Cells were lysed at the indicated time and assayed for expression of
luciferase. Values were normalized for cytoplasmic protein content. Data represent the mean "SD for triplicates after correction for
background.
stuck to the surface in such a way that it could not be
washed off. The results also suggest that phosphate
buffer possibly accelerates the gene delivery process.
One hour treatment was sufficient to elicit the maxi-
mal effect, and exposing the cells to the transfection
mix for additional hours did not result in further
increases in gene expression. In the control experi-
ment maximal gene expression was significantly less
than that which could be reached with phosphate
buffer stimulation. In addition, more than 2 h were
required to reach the maximal transfection efficiency.
In the second time course experiment all cells were
treated for 1 h with the two types of transfection
mixes described above. At the end of the 1 h treat-
ment, the mix was removed, the cells were further
incubated for 1–24 h, and lysed and assayed at the
indicated time points. Luciferase activity was below
detection level after 1 h of incubation, which coin-
 .cided with the 1 h treatment period not shown .
 .Results presented in Fig. 8 B demonstrate that at
least 2 h incubation was required to detect luciferase
activity. By that time the measured luciferase activity
was 500-fold of the background level in cells lipo-
fected with phosphate-treated samples while the same
value was only 27-fold in cells lipofected with the
conventional method. These results suggest that in
HOS cells intracellular trafficking, transcription and
translation of luciferase encoding plasmid DNA takes
about 2 h to occur and about 5 h to reach its maximal
capacity. Additional incubation up to 24 h resulted
only in a marginal 1.6- and 3.5-fold further increase
in gene expression elicited by the phosphate buffer-
mediated and control transfections, respectively.
These results also suggest that the DNA–lipid com-
plex, made with phosphate buffer, requires less time
to be expressed in higher quantities compared to the
control complex made without the buffer. To insure
that results of time courses are not skewed by the
presence of limited amounts of transfective complex,
we reused the transfection solution removed from the
cells in a second set of time course experiments. With
the reused transfection mix we obtained results simi-
 .lar to those shown in Fig. 8 B . Surprisingly, we
 .could generate curves almost identical to Fig. 8 B ,
confirming that the original experiment was per-
formed in the presence of excess effective complex.
This result also demonstrates that both types of com-
plexes are very stable.
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3.8. Time course of mRNA transfection
To understand the mechanism by which the phos-
phate buffer affects efficiency of gene transfection
we needed to determine more precisely the time
frame of cellular uptake and processing of transgene
to protein product. To achieve this we performed
time course studies using mRNA and plasmid DNA.
The nucleic acids were complexed with lipofectin
that was pretreated with 30 mM potassium phosphate
pH 5.8. Cells were treated with the transfection mixes
for 1 h at which time the mix was replaced with
prewarmed medium containing 10% FCS, unless the
cells were lysed and assayed at an earlier time point.
Cells were harvested at various time points after
initiation of transfection. Results of the experiment
are shown in Fig. 9. Much to our surprise at 15 min
after exposing the cells to mRNA–lipid complex we
could detect very significant amounts of luciferase
Fig. 9. Kinetics of phosphate-enhanced RNA and DNA transfec-
tion. Time course experiments. Transfection and luciferase assay-
ing were performed as described in Fig. 1 and in Section 2.
Complex was prepared by mixing 0.23mg luciferase-encoding
 .  .mRNA mTEV-LUC-A50 filled triangles or plasmid DNA
 X.  .pCMVintLucD5 filled circles with 0.8 mg lipofectin that was
preincubated with DMEM containing 100ngrml BSA and 30 mM
potassium phosphate pH 5.8 prior to complexing. Cells were
incubated for 1 h with the transfection mixes, then the transfec-
tion mix was replaced with culture medium and they were further
incubated unless the cells were lysed and assayed at earlier time
points. Cells were lysed at the indicated time following the
initiation of transfection and assayed for expression of luciferase.
Values were normalized for cytoplasmic protein content.
activity in the cells. The luciferase expression elicited
by the mRNA transfection was extremely rapid and
the mRNA translation was almost at its full capacity
in the first hour. Meanwhile, under the same experi-
mental setting, luciferase expression from the plasmid
DNA followed a kinetic similar to the one presented
 .in Fig. 8 B . These experiments clearly demonstrate
that the cellular uptake of the lipid–mRNA complex
formed in the presence of phosphate buffer proceeds
very quickly and that the majority of mRNA proba-
bly enters directly to the cytoplasm where translation
occur almost instantly. This also suggests that the
extended time needed for luciferase expression from
the plasmid DNA vs. mRNA is probably required for
nuclear transport of the DNA, transcription and cyto-
plasmic relocation of the in vivo made transcript.
In some experiments the expression of luciferase
 .was followed for an extended time period not shown .
Abundant luciferase expression was maintained for
up to 8 h when mRNA was transfected to the cells.
By 24 and 48 h, expression declined to about 4% and
1% of the maximal level, suggesting that both the
luciferase mRNA and protein are labile in HOS cells.
Following DNA transfection, we determined that by
day 2 the expression had declined to 20% of the day
1 level. A further gradual decline was detected up to
day 4, at which point 10% of day 1 level luciferase
could be detected, suggesting that both transcription
and translation have been sustained, though at a
lower level, for 4 days.
4. Discussion
One of the goals of this study was to improve
cationic lipid-mediated mRNA and plasmid DNA
transfection by exploiting the stimulatory effect of
phosphate anions on lipofection. The other goal was
to use this improved transfection technique to gain
insight into the mechanism of lipofection, and subse-
quently understand the processes by which phosphate
exerts its effect.
We have demonstrated that the phosphate anion-
evoked processes improved lipofection by expediting
transgene expression and also by increasing the
amount of synthesized transgene products. These ef-
fects of phosphate were specific in that other tested
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compounds could not generate similar enhancement.
It was also shown that the enhancement of gene
expression depended upon the concentration and pH
of the phosphate initiated effect.
A combination of electrostatic and hydrophobic
interactions play crucial roles during complex forma-
tion and transfection when molecules such as the
negatively charged DNA and cell membranes and the
positively charged lipofectin are in contact within
themselves and with each other. These interactions
intrinsically are dependent on the ionic characteristics
of the solution in which they are present. Therefore
we can identify the following three important interac-
tions in which the presence of phosphate anions in
the solution can potentially exert their effect, leading
to improved transfection. The first is the lipofectin–
lipofectin interaction, the second is the lipofectin–
nucleic acid interaction, and the third is the cell
membrane interaction with the nucleic acidrlipo-
fectin complex.
First consider the interaction between lipofectin–
lipofectin in a lipofectin dispersion. It is possible that
the effect of the negatively charged phosphate anion
on the positively charged lipofectin is analogous to
the long appreciated effect of divalent cations on the
w xnegatively charged phospholipid bilayers 28,29 . It
 2qhas been demonstrated that divalent cations i.e. Ca ,
2q.  q.Ba but not monovalent cations i.e. Na induce
membrane fusion when a critical amount of divalent
w xcation is bound per phospholipid molecule 30,31 ,
and indeed, Duzgunes et al. have shown that it is¨ ¨
probable that divalent anions such as phosphate in-
duce fusion of cationic lipids through the formation
of a complex between positive charges present on the
w xopposed lipid bilayers 15 . Phosphate anion was
found to be fusogenic when it was present at 20 mM
or higher concentration at pH 7.4. Monovalent anion
w xsuch as acetate did not induce membrane fusion 15 .
The conditions that we utilized for the lipofectin
preincubation step was very similar to the above
described condition in which phosphate anions in-
duced fusion of cationic lipids. We achieved maximal
transfection efficiency when the phosphate concentra-
tion was 30–80 mM during the lipofectin preincuba-
tion step. We determined a pH optimum of 5.6–6.8
under which the phosphate is present as divalent
anion. We also identified that monovalent anions
such as acetate and Cly, which have been shown to
w xnot induce membrane fusion 15 , did not enhance the
 .transfection efficiency Fig. 2 . These results suggest
a potential correlation between cationic lipid fusion
and increased transfection efficiency.
The second interaction that can potentially be in-
fluenced by the presence of phosphate anions occurs
between the lipofectin and nucleic acid. Several mod-
els have been proposed to describe the morphologi-
cally distinct structures detected by analyzing com-
plexes formed during nucleic acid and cationic lipo-
some interactions. Depending primarily on the detec-
tion techniques employed, nucleic acid are described
w xas being encapsulated within 18 or ensheated be-
w xtween lipid bilayers 19 , or to be bound to the
w xexterior surface of the lipid vesicles 20 . In addition,
recent studies have identified the complexes as highly
organized lamellar structures in which two-dimen-
sionally condensed DNA molecules are sandwiched
w xbetween cationic bilayers 23 . Despite the differ-
ences, all models fundamentally agrees, that the pre-
dominant interactions that lead to the formation and
subsequently maintain the proposed structures are
w xelectrostatic in nature. It has been reported 23 , that
as a result of the electrostatic interactions the phos-
phate groups on the nucleic acids are likely to be
neutralized by the cationic lipid, while the originally
condensed counterions get released from both com-
ponents. Thus, it is possible that phosphate-pretreat-
ment of cationic lipid dispersion might result in
formation of special lipid intermediates that are capa-
ble to promote nucleic acid condensation, and subse-
quently, to improve transfection efficiency. Such an
explanation is also supported by a report concerning
correlations between transfection activity and DNA
w xcondensation 21 .
The third interaction which can potentially be in-
fluenced by phosphate anion is the cellular uptake of
the nucleic acidrlipofectin complex. Goodarzi et. al.
reported that in the presence of low pH phosphate
buffer oligonucleotides bind to the cell membrane at
w xmuch higher efficiency than at neutral pH 32 . The
bound oligonucleotides could be competed off with
plasmid DNA and tRNA or eluted from the mem-
brane at pH 7.5. Under our experimental conditions it
seemed that the phosphate was more effective when
the pH was in the acidic range, therefore we tested
whether increased nucleic acid binding to the cells
under low pH phosphate condition could account for
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the observed increased transfection efficiency. We
tested whether washing the cells at pH 7.5 following
transfection could diminish the phosphate-mediated
increase of transgene expression. We found no differ-
ence in transfection efficiency when the cells were
washed with high pH phosphate buffer following
 .lipofection not shown , suggesting that the phos-
phate-enhanced transgene expression is not mediated
by increased nucleic acid binding to specific recep-
w xtors such as described by Goodarzi 32 .
Physico-chemical studies simulating the interac-
tions between the complex and the cell membrane
suggested the following potential entry mechanism.
After contact, the complex initiates destabilization of
the membrane by flip-flop of the anionic lipids from
the membrane. The anionic lipids diffuse to the com-
plex and displace the DNA from the complex permit-
w xting the DNA to enter the cytoplasm 17 . It has also
been demonstrated that negatively charged water sol-
uble molecules can also displace the DNA from the
complex. Interaction with these water soluble
molecules in the extracellular space could interfere
with transfection resulting in premature release of the
DNA to the medium rather than to the cytoplasm.
Interestingly none of the tested phosphate containing
w xmolecules had such a DNA replacing activity 17 .
It has long been appreciated in studies of lipofec-
tion that one of the many variables which affects the
efficacy of gene expression is the medium used for
w xlipid:DNA complex formation 13 . However, we are
aware of only one study in which the effect of
different counter anions of a cationic lipid on the
transfection efficiency has been directly addressed.
Performing a systematic study, Aberle et al. reported
that bisulfate counter anion had the highest stimula-
w xtory effect on transfection 33 . The effects of phos-
phate and acetate anions were negligible. These re-
sults contradict our finding, but the sample prepara-
tion might explain the discrepancies. Aberle et al.
added counterions to the lipids by ion exchange
chromatography, rather than by preparing the lipid
dispersion in a buffer containing excess of the anion,
w xas we have done 33 .
w xIt has been reported 27 , and we also found, that
cationic lipid dispersions are more toxic without nu-
  .  ..cleic acid than with nucleic acid Fig. 5 B vs. D .
In addition we have demonstrated that phosphate
preconditioning can also inhibit lipofectin-induced
  .  ..cell toxicity Fig. 5 B vs. C . Other phosphate
containing molecules such as tRNA were also re-
ported to inhibit lipid-mediated cytotoxicity resulting
in the use of tRNA routinely as a carrier during
w xcomplex formation and transfection 5 . The phos-
phate-mediated reduction of lipofectin-evoked toxic-
ity could be due to a shielding effect of phosphate
anions on the excess charges of the lipofectin. A
w xrecent observation reported by Li and Hui 34 sup-
ports this explanation. While investigating the cationic
liposome-induced cell toxicities, they found that
 .phosphate buffered saline PBS , which contains
5 mM polyvalent phosphate anions, reduced cationic
w xlipid-induced cell–cell fusion and cell lysis 34 .
Analyzing the kinetics of mRNA and DNA trans-
fection, we determined that at higher nucleic acid
 .concentration 0.1–0.3 mg nucleic acidrwell the
transfection efficiency was not concentration depen-
 .dent Figs. 6 and 7 . By diluting or repeatedly reusing
the transfection mix we have demonstrated that the
transfection mix contains a huge excess of transfec-
tionally active complex. However the cellular uptake
 .of those complexes are limited Fig. 7 . Using FACS
analysis we have found that phosphate-enhanced
transfection of the urokinase receptor-encoding
mRNA resulted in transgene expression in 89% of
the targeted cells K. Kariko, A. Kuo, E.S. Bar-´
.nathan, unpublished data . These data suggest that
following phosphate-enhanced transfection most of
the cells are expressing the transgene and higher
levels of expression of transgene by individual cells
is limited. The limitation is probably at the cellular
uptake level. It has long been recognized that relative
efficiency of naked polynucleotide uptake by the
cells dramatically diminishes at high polynucleotide
w xconcentration 35 . However, using lipofectin-media-
ted gene delivery there was a linear relationship
between the quantity of transfected mRNA or plas-
mid DNA and the quantity of synthesized proteins
w xencoded by the nucleic acids 5,10 . We are not
aware, however, of any studies where transfectability
of already used transfection mix was tested. To un-
derstand why the cells cannot take up more complex
needs further investigation.
Analysis of the time courses of DNA and RNA-
mediated transgene expression demonstrated that
phosphate preconditioning significantly accelerated
both cellular uptake and transgene expression Figs. 8
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.and 9 compared to those reported by conventional
w xlipofection 4,5,12,13 . This acceleration was not lim-
ited to HOS cells, because almost identical time
courses could be obtained using NIH 3T3 and K562
 .cell lines not shown . In addition, our data also
demonstrate a synergistic effect between lysoso-
motropic chloroquine and phosphate, suggesting that
the classic endosomal escape is an unlikely mecha-
 .nism for the phosphate-mediated effects Fig. 1 .
Therefore it is possible that nucleic acids, in the
presence of phosphate anion, are more efficiently
encapsulated to a condensed structure, more easily
cross the membranes of the cells and the endosomes,
and become readily translatable resulting in superior
non-viral gene transfection efficiency.
In summary, we have described here the superior
characteristics of a non-viral, lipofectin-mediated
mRNA- and plasmid DNA-based transfection. The
highly transfective material was made by complexing
nucleic acid with lipofectin that was pretreated with
phosphate buffer. Although further study will be
required to define the exact mechanisms, our findings
support a hypothesis that could explain the phos-
phate-mediated enhancement. Divalent phosphate an-
ions might induce fusion of the cationic lipid vesicles
aggregated along the nucleic acid chains. Such a
fusion could result in a more efficient nucleic acid
encapsulation and subsequent formation of highly
transfective particles.
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